Agreement - May 15, 2018
BC Platforms collaborates with Google Cloud
BC Platforms has partnered with Google Cloud to deliver its genomics and clinical data solutions to hospital and industry partners worldwide. In addition to storage, archiving and calculation capacity, Google Cloud genomics and AI tools, including DeepVariant, will be supported. “We are excited to collaborate with BC Platforms to provide their highly scalable and fully integrated service offering in […]
Agreement - May 8, 2018
AstraZeneca and Luye Pharma Group enter agreement
AstraZeneca has entered into an agreement with Luye Pharma Group for the sale and licence of the rights to Seroquel and Seroquel XR in the UK, China and other international markets, including Brazil, Australia, Saudi Arabia, Mexico, South Korea, Thailand, Argentina, Malaysia and South Africa. The transaction is part of AstraZeneca’s strategy to focus on its three main therapy […]
Agreement - April 17, 2018
TFS International in new agreement
TFS International has announced an agreement with the Pharma Intelligence division of Informa for their global research and development (R&D) platform – Citeline. “At TFS we are already proud of the strategic and operational services that we provide our biotechnology and pharma clients.” said Dr Saleh. “This agreement with Citeline will take us to the next […]
Agreement - March 19, 2018
Bavarian Nordic in new alliance with the US Department of Defense
The company has entered an agreement with the United States Department of Defense (DoD) for the development of a prophylactic vaccine against the equine encephalitis virus-a rare, but potentially deadly mosquito-borne illness. With funding from the DoD, Bavarian Nordic will utilize its MVA-BN platform to develop a vaccine against various strains of the virus, for […]
Agreement - February 19, 2018
SenzaGen signs licensing agreement
The company has signed a global licensing agreement with the contract research organization Eurofins BioPharma Product Testing Munich (Eurofins BPT Munich), to market the GARD test to its clients. GARD is a genome-based test that gives the customers safety information whether chemical substances are at risk of causing allergies in humans. Eurofins BioPharma Product Testing […]
Agreement - January 25, 2018
Alligator contracts Theradex Oncology as clinical CRO
Alligator Biosciencehas appointed Theradex Oncology as CRO for their planned phase I study of ATOR-1015 for the treatment of metastatic cancer. The upcoming clinical phase I study with ATOR-1015 is a first-in-human dose escalation study in patients with metastatic cancer. The study will be conducted at five sites in Sweden and Denmark. “Engaging Theradex is a key step […]
